Filing Details

Accession Number:
0001179110-16-033153
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2016-12-16 17:53:59
Reporting Period:
2016-12-08
Filing Date:
2016-12-16
Accepted Time:
2016-12-16 17:53:59
Original Submission Date:
2016-12-12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1061027 Sunesis Pharmaceuticals Inc SNSS Pharmaceutical Preparations (2834) 943295878
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1491874 M. Geoffrey Parker 395 Oyster Point Blvd.
Suite 400
San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-08 3,146 $3.87 13,480 No 4 P Direct
Common Stock Acquisiton 2016-12-09 594 $3.90 14,074 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $3.80 to $3.93, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) of this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $3.79 to $3.95, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) of this Form 4.